Literature DB >> 10807497

Augmented prostaglandin E2 generation resulting from increased activities of cytosolic and secretory phospholipase A2 and induction of cyclooxygenase-2 in interleukin-1 beta-stimulated rat calvarial cells during the mineralizing phase.

S Higashi1, H Ohishi, I Kudo.   

Abstract

OBJECTIVE AND
DESIGN: To assess prostaglandin (PG) E2 production by osteoblasts during the mineralizing phase after interleukin (IL)-1beta stimulation, using an in vitro system of rat calvarial cells cultured for 21 days.
METHODS: The cells, which reached confluence after 3 days, were designated day 0 cells. Culture was continued for a further 21 days after confluence. The cells on the 21st day of the culture were designated day 21 cells.
RESULTS: The PGE2 concentration in the medium of the day 21 cells was increased 72 h after IL-1beta treatment, and reached a peak level approximately 1,400 times that of the day 0 cells 6 h after IL-1beta treatment. We examined the effects of IL-1beta on PGE2 production and changes in the relevant enzyme activities, and found that the activities of cytosolic phospholipase A2 (cPLA2), type II secretory PLA2 (sPLA2) and cyclooxygenase (COX)-2 in the day 21 cells were increased. Both selective COX-2 inhibitor and cPLA2 inhibitor abolished PGE2 generation, whereas an sPLA2 inhibitor partially inhibited it. Taken together, these results indicate that COX-2 and cPLA2 play pivotal roles and sPLA2 is involved in IL-1beta-stimulated PGE2 production by these cells. Furthermore, we found that IL-Ibeta treatment induced PGE synthase activity and this correlated well with PGE2 production.
CONCLUSION: Augmented PGE2 production by mineralizing osteoblasts after IL-1beta treatment, and the involvement of IL-1beta-induced cPLA2, sPLA2, COX-2 and PGE synthase activities in this phenomenon were demonstrated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807497     DOI: 10.1007/s000110050566

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  6 in total

1.  PLIP, a novel splice variant of Tip60, interacts with group IV cytosolic phospholipase A(2), induces apoptosis, and potentiates prostaglandin production.

Authors:  A M Sheridan; T Force; H J Yoon; E O'Leary; G Choukroun; M R Taheri; J V Bonventre
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

3.  Acute reactogenicity after intramuscular immunization with recombinant vesicular stomatitis virus is linked to production of IL-1β.

Authors:  Kathleen Athearn; Christopher J Sample; Brice E Barefoot; Kristi L Williams; Elizabeth A Ramsburg
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

4.  Calcium-Dependent Cytosolic Phospholipase A2α as Key Factor in Calcification of Subdermally Implanted Aortic Valve Leaflets.

Authors:  Antonella Bonetti; Magali Contin; Federica Tonon; Maurizio Marchini; Fulvia Ortolani
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

5.  Critical Involvement of Calcium-Dependent Cytosolic Phospholipase A2α in Aortic Valve Interstitial Cell Calcification.

Authors:  Antonella Bonetti; Lorenzo Allegri; Federica Baldan; Magali Contin; Claudio Battistella; Giuseppe Damante; Maurizio Marchini; Fulvia Ortolani
Journal:  Int J Mol Sci       Date:  2020-09-03       Impact factor: 5.923

6.  Modulation of Endocannabinoid Tone in Osteoblastic Differentiation of MC3T3-E1 Cells and in Mouse Bone Tissue over Time.

Authors:  Magdalena Kostrzewa; Ali Mokhtar Mahmoud; Roberta Verde; Federica Scotto di Carlo; Fernando Gianfrancesco; Fabiana Piscitelli; Alessia Ligresti
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.